ITGB2 and adenocarcinoma: Although control samples had higher CD18 expression than tumor samples, this difference was not significant when comparing adenocarcinoma samples with control samples [Kruskal-Wallis test, 1.75 (1–2) vs 2.3 (1.7–3) p > 0.1].